COMMUNIQUÉ DE PRESSE publié le 23/08/2024 à 18:15, il y a 1 année 7 mois aap Implantate AG: annual financial statements 2023 characterized by the difficult economic environment and restructuring measures introduced, good operational progress aap Implantate AG's annual financial statements for 2023 show progress despite economic challenges and restructuring efforts. Sales increased initially but faced obstacles later Sales Financial Statements Restructuring Aap Implantate AG Economic Challenges
BRÈVE publiée le 22/08/2024 à 18:10, il y a 1 année 7 mois Aap Implantate AG Faces Audit Impediments Financial Statements 2023 Annual Report Aap Implantate AG Audit Impediments Baker Tilly
BRÈVE publiée le 22/08/2024 à 18:10, il y a 1 année 7 mois Aap Implantate AG fait face à des obstacles en matière d'audit Aap Implantate AG États Financiers Rapport Annuel 2023 Obstacles À L'audit Boulanger Tilly
COMMUNIQUÉ DE PRESSE publié le 22/08/2024 à 18:05, il y a 1 année 7 mois EQS-Adhoc: aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments aap Implantate AG's auditor Baker Tilly GmbH & Co KG will not issue an opinion on the annual financial statements due to audit impediments. The Company faces potential penalty and is resolving issues for future audits Financial Statements Aap Implantate AG Audit Impediments Baker Tilly GmbH Penalty
BRÈVE publiée le 14/08/2024 à 19:20, il y a 1 année 8 mois Aap Implantate AG Reports Balanced EBITDA for H1/2024 EBITDA Cash Flow Sales Growth Financial Outlook Trauma Division
BRÈVE publiée le 14/08/2024 à 19:20, il y a 1 année 8 mois Aap Implantate AG annonce un EBITDA équilibré pour le premier semestre 2024 EBITDA Croissance Des Ventes Perspectives Financières Des Flux De Trésorerie Service De Traumatologie
COMMUNIQUÉ DE PRESSE publié le 14/08/2024 à 19:15, il y a 1 année 8 mois Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA aap Implantate AG reports balanced EBITDA with positive results in trauma business for the first half of 2024. Sales increased by 10% to EUR 6.4 million, driven by EMEA region growth. Key figures include stable gross margin and improved EBITDA Financial Results EBITDA Medical Technology Sales Growth Aap Implantate AG
BRÈVE publiée le 15/07/2024 à 07:35, il y a 1 année 9 mois Aap Implantate AG Reports Positive Sales Growth for Q2 and H1 2024 Medical Technology Sales Growth Clinical Trials Market Expansion Regional Performance
BRÈVE publiée le 15/07/2024 à 07:35, il y a 1 année 9 mois Aap Implantate AG annonce une croissance positive de ses ventes pour le deuxième trimestre et le premier semestre 2024 Essais Cliniques Technologie Médicale L'expansion Du Marché La Croissance Des Ventes Performance Régionale
COMMUNIQUÉ DE PRESSE publié le 15/07/2024 à 07:30, il y a 1 année 9 mois Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas aap Implantate AG reports sales growth of 14% in Q2/2024 and 10% in H1/2024 compared to the previous year, with positive developments across all operating regions Sales Growth Aap Implantate AG Antibacterial Implant Technology Q2/2024 H1/2024
Publié le 17/04/2026 à 20:30, il y a 1 jour 20 heures ALTAREA - Déclaration d’opérations sur actions propres
Publié le 17/04/2026 à 19:00, il y a 1 jour 21 heures Cegedim : Publication du Document d’Enregistrement Universel 2025
Publié le 17/04/2026 à 19:00, il y a 1 jour 21 heures Cegedim: Release of its 2025 Universal Registration Document
Publié le 17/04/2026 à 17:45, il y a 1 jour 23 heures Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Publié le 17/04/2026 à 17:45, il y a 1 jour 23 heures Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın
Publié le 18/04/2026 à 04:00, il y a 1 jour 12 heures Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Publié le 18/04/2026 à 02:00, il y a 1 jour 14 heures AI/ML Innovations Announces Completion of Share Issuance
Publié le 18/04/2026 à 01:35, il y a 1 jour 15 heures Medicure Announces Resignation of President and Chief Operating Officer
Publié le 18/04/2026 à 01:00, il y a 1 jour 15 heures Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Publié le 18/04/2026 à 00:00, il y a 1 jour 16 heures Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Publié le 18/04/2026 à 00:05, il y a 1 jour 16 heures ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Publié le 17/04/2026 à 21:39, il y a 1 jour 19 heures Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Publié le 17/04/2026 à 20:33, il y a 1 jour 20 heures LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Publié le 17/04/2026 à 19:30, il y a 1 jour 21 heures KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS